Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is characterized by dysregulated antiviral immune responses.
• The IFIH1 gene, encoding the MDA-5 protein, is implicated in SLE pathogenesis.
• Previous studies established associations between SLE and IFIH1 in mice.

Purpose of the Study:

• To investigate the association of IFIH1 gene variants with soluble inflammatory mediators in human SLE.
• To extend findings from mouse models to the human ortholog IFIH1 in the context of SLE.

Main Methods:

• Genotyping of 135 single nucleotide polymorphisms (SNPs) in the IFIH1 gene.
• Analysis of associations between IFIH1 SNPs and plasma levels of IL-6, TNF-α, IFN-β, and IP-10 in 357 European-American SLE patients, first-degree relatives (FDRs), and controls.
• Linear regression models were used to assess associations.

Main Results:

• No significant associations were found for SNPs in the region orthologous to mouse exon 13.
• Significant associations were identified between IL-6 and SNP rs76162067 (p = 0.008) and between IP-10 and SNP rs79711023 (p = 0.003).
• Carriers of the minor allele for rs79711023 showed lower IP-10 levels, while carriers of the minor allele for rs76162067 showed increased IL-6 levels, with differential effects in SLE patients versus FDRs.

Conclusions:

• IFIH1 variants outside the previously studied mouse exon 13 region are associated with key inflammatory mediators in SLE.
• The observed genotype-specific alterations in IP-10 and IL-6 levels suggest a role for IFIH1 in SLE pathogenesis through modulation of inflammatory pathways.
• These findings highlight the potential contribution of IFIH1 to SLE development and progression.